Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms
Departments of Ophthalmology and Molecular Genetics and Microbiology, Duke University Medical Center, Erwin Road, Durham, NC 27710, USA
* To whom correspondence should be addressed. Tel: +1 919-684-8457; Fax: +1 919-684-3826; Email: ferre044{at}mc.duke.edu
Received May 6, 2005; Accepted August 1, 2005
In the past decade, we have witnessed great advances in the identification of genes underlying numerous neurodegenerative diseases and the stark complexity determining genotype–phenotype relationships that lead to the impairment, and ultimately, premature death of neurons. However, significant challenges lie ahead in understanding the pathobiological and spatiotemporal processes triggered by genetic lesions underlying neurodegenerative disorders. Neuroretinal dystrophies occupy a prominent place among neurodegenerative diseases, because of the large number and prevalence of disease-causing genes, the diverse functions, the wealth of allelic, non-allelic and clinical heterogeneities determining the phenotypic expressivity and penetrance of the disease and the ease of use of animal models to probe gene function and disease pathogenesis in a well-defined neuroretinal circuitry. Retinitis pigmentosa (RP) has a prevalence of about one in 4000. RP is a retinal dystrophy leading primarily to the progressive death of photon-capturing neurons—the rod photoreceptors. X-linked retinitis pigmentosa type 3 (XlRP3) accounts up to 14% of all RP cases, higher than any other single RP locus identified to date, and considered to be the most severe of all RP cases. The XlRP3 encodes the retinitis pigmentosa GTPase regulator (RPGR). RPGR interacts with the RPGR interacting protein-1 (RPGRIP1). Mutations in RPGRIP1 cause Leber's congenital amaurosis. This review highlights the progress devoted to understand the pathogenesis associated with XlRP3 and allied disorders and, concepts, trends and discrepancies emerging as molecular, subcellular and physiological processes linked to RPGR and RPGRIP1-protein network begin to be elucidated, and that may serve as a paradigm for other biological processes and neurodegenerative diseases.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Won, E. Gifford, R. S. Smith, H. Yi, P. A. Ferreira, W. L. Hicks, T. Li, J. K. Naggert, and P. M. Nishina RPGRIP1 is essential for normal rod photoreceptor outer segment elaboration and morphogenesis Hum. Mol. Genet., November 15, 2009; 18(22): 4329 - 4339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yi, J. L. Friedman, and P. A. Ferreira The Cyclophilin-like Domain of Ran-binding Protein-2 Modulates Selectively the Activity of the Ubiquitin-Proteasome System and Protein Biogenesis J. Biol. Chem., November 30, 2007; 282(48): 34770 - 34778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Moore, M. P. Gelderman, P. A. Ferreira, S. R. Fuhrmann, H. Yi, A. Elkahloun, L. M. Lix, R. O. Brady, R. Schiffmann, and E. Goldin Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach PNAS, May 8, 2007; 104(19): 8065 - 8070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Garcia-Hoyos, B. Garcia-Sandoval, D. Cantalapiedra, R. Riveiro, I. Lorda-Sanchez, M. J. Trujillo-Tiebas, M. Rodriguez de Alba, J. M. Millan, M. Baiget, C. Ramos, et al. Mutational Screening of the RP2 and RPGR Genes in Spanish Families with X-Linked Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3777 - 3782. [Abstract] [Full Text] [PDF]
|
|